Cognition Therapeutics, Inc. (NASDAQ:CGTX) has received a new composition of matter patent from the US Patent and Trademark Office (USPTO) covering a crystalline form of its investigational drug ...
Composition of matter provides U.S. protection through Sept. 6, 2044, as forazapadin advances in Phase 2 developmentTORONTO, ...
The patent world tends to think that the Supreme Court’s framework in Alice 1 is a template for determining the eligibility of software and business method inventions 2. Under 35 U.S.C. § 101, ...
Earlier this month, the Federal Circuit decided a subject matter eligibility case closely watched in the pharmaceutical industry. The case involved composition-of-matter claims reciting measured ...
SAN DIEGO--(BUSINESS WIRE)--Sinopia Biosciences, Inc., a biotechnology company advancing novel therapeutics discovered using its proprietary LEADS® (LEarn And DiScover) drug discovery platform, today ...
The United States International Trade Commission (ITC) is often seen as a pro-patentee venue — but not for US Synthetics and its attempts to enforce its patents covering drill bit diamond tips. In its ...
“The dispute in this case centers around the recited magnetic properties… and their relationship to the claimed [polycrystalline diamond compound].” – CAFC The ITC instituted a Section 337 ...
MELBOURNE, Australia and SAN FRANCISCO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or“the Company”), a biotechnology company dedicated to developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results